Document Detail


HDL-cholesterol level and cortisol response to synacthen in critically ill patients.
MedLine Citation:
PMID:  14566456     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
OBJECTIVE: To explore the relationship between cholesterol levels and the adrenal cortisol response to synacthen in critically ill patients. DESIGN: Prospective observational study. PATIENTS: Critically ill patients with multiple organ dysfunction syndrome (MODS) with possible adrenal dysfunction defined as unexplained hypotension, ongoing inotropic support, unexplained fever, unexplained hyponatraemia or a combination of these symptoms. MEASUREMENTS: HDL-cholesterol levels (HDL), total cholesterol levels (TC), and triglycerides (TG) before administration of synacthen. LDL-cholesterol was calculated using the Friedewald formula. Basal cortisol and response to 250 microg synacthen intravenously was measured. A cortisol rise of 0.25 micromol/l in a 30-min or 60-min blood sample after synacthen infusion was defined as a proper adrenal response. RESULTS: Patients with a proper response to synacthen showed higher HDL-cholesterol levels than patients without that response ( P=0.02). Severity of disease as measured by APACHE II or SOFA was not a confounder. LDL-cholesterol levels were extremely low in both responders and non-responders and were not associated with the absolute rise in cortisol. In linear and logistic regression analysis HDL-cholesterol was the sole predictor of cortisol response. CONCLUSIONS: Adrenal cortisol response to a "classic" 250-microg synacthen test relates in critically ill patients to HDL-cholesterol levels. LDL and TC levels did not show such a relation. These findings are in concordance with known biochemical pathways of cortisol production.
Authors:
Peter H J van der Voort; Rik T Gerritsen; Andries J Bakker; E Christiaan Boerma; Michael A Kuiper; Loek de Heide
Related Documents :
7698286 - Effect of intralipid infusion on serum high- and low-density lipoprotein cholesterol, l...
19888036 - Effect of injectable and oral contraceptives on serum lipids.
8892766 - Changes in plasma lipids and lipoproteins associated with starting or stopping postmeno...
20116656 - Optimal cutoff value of high-density lipoprotein cholesterol for predicting coronary ar...
2277606 - Aminoaciduria of phosphate depletion manifests at the renal brush border membrane.
8064696 - Effects of dietary zinc deficiency on the reproductive system of young male sheep: test...
Publication Detail:
Type:  Clinical Trial; Journal Article     Date:  2003-10-18
Journal Detail:
Title:  Intensive care medicine     Volume:  29     ISSN:  0342-4642     ISO Abbreviation:  Intensive Care Med     Publication Date:  2003 Dec 
Date Detail:
Created Date:  2003-12-03     Completed Date:  2004-04-13     Revised Date:  2006-11-15    
Medline Journal Info:
Nlm Unique ID:  7704851     Medline TA:  Intensive Care Med     Country:  United States    
Other Details:
Languages:  eng     Pagination:  2199-203     Citation Subset:  IM    
Affiliation:
Department of Intensive Care, Medical Centre Leeuwarden, PO Box 888, 8901 BR, Leeuwarden, The Netherlands. phjvdvoort@wxs.nl
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Adult
Aged
Aged, 80 and over
Cholesterol, HDL / blood*
Cosyntropin / therapeutic use*
Critical Care
Humans
Hydrocortisone / blood*
Logistic Models
Middle Aged
Multiple Organ Failure / blood,  drug therapy*
Prospective Studies
Severity of Illness Index
Treatment Outcome
Chemical
Reg. No./Substance:
0/Cholesterol, HDL; 16960-16-0/Cosyntropin; 50-23-7/Hydrocortisone; 53468-06-7/adrenocorticotropin zinc

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Clinical pulmonary infection score for ventilator-associated pneumonia: accuracy and inter-observer ...
Next Document:  Electrical impedance tomography: a method for monitoring regional lung aeration and tidal volume dis...